Hematology drugs market offers drugs, blood and blood products that are used for the treatment of diseases such as rare genetic disorders, anemia, and conditions related to sickle cell disease and other related diseases. Some of the major hematology drugs include Albumin, Epoetin, Zoladex, and Hyskon.
Read the report at
The substantial growth of the market from $40 billion in 2017 to around $52 billion by 2021 is due to the unhealthy lifestyle of consumers leading to anemia and coagulation disorders. Factors such as increased longevity and the launch of pipeline drugs will also drive the market for hematology drugs.
In the report, the hematology drugs market is divided into blood products and anemia and other blood disorder drugs, with blood products occupying the major market share (nearly 70%) and remaining is occupied by anemia and other blood products.
Download a sample of the report at
The USA was the largest country in the hematology drugs market in 2017, accounting for 30% of the market share. This was mainly due to high drug prices and high healthcare spending in the USA compared to other countries. China and Brazil followed the USA as the next largest countries in the market.
The hematology drugs market is fragmented with a number of large and small organizations. The top five competitors in the market made up around 25% of the total market in 2017. Novo Nordisk A/S was the largest competitor followed by Shire Plc., Bayer AG, Daiichi Sankyo Company Limited and Biogen Inc. Novo Nordisk A/S is a healthcare company involved in discovering, developing, manufacturing, and marketing of pharmaceutical products. Novo Nordisk markets and distributes its products through distributors and independent agents worldwide.
About The Business Research Company.
The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: [email protected]